Status:
COMPLETED
Device for Age-related Macular Degeneration (AMD)
Lead Sponsor:
University of Michigan
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
18+ years
Brief Summary
This study involves user acceptability and feedback of KalEYEdoscope, a digital, handheld device utilizing shape-discrimination hyperacuity to distinguish the severity of age-related macular degenerat...
Detailed Description
This is a patient-experience study being conducted at the Kellogg Eye Center in Ann Arbor in the outpatient setting. Patients who agree to enroll in the study will test the device and provide user fee...
Eligibility Criteria
Inclusion
- Any patient aged 18 years or older with age-related macular degeneration who is seen at the Kellogg Eye Center.
Exclusion
- pregnant women, prisoners, severe cognitive impairment, and diagnoses (mental or neuromuscular disorders) which could preclude independent use of the device.
Key Trial Info
Start Date :
March 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 25 2022
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06178978
Start Date
March 10 2022
End Date
March 25 2022
Last Update
December 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan, United States, 48105